Invesco Nasdaq Biotechnol... (IBBQ)
NASDAQ: IBBQ
· Real-Time Price · USD
23.43
-0.05 (-0.23%)
At close: Aug 18, 2025, 3:59 PM
-0.23% (1D)
| Bid | 20.9 |
| Market Cap | 34.05M |
| AUM | 35.9M |
| NAV | 23.48 |
| EPS (ttm) | 0.86 |
| PE Ratio (ttm) | 27.31 |
| Shares Out | 1.45M |
| Inception Date | Jun 11, 2021 |
| Ask | 26.46 |
| Volume | 7.21K |
| Open | 23.55 |
| Previous Close | 23.48 |
| Day's Range | 23.41 - 23.60 |
| 52-Week Range | 17.84 - 24.84 |
| Holdings | 256 |
| Expense Ratio | 0.19% |
About IBBQ
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Asset Class Equity
Ticker Symbol IBBQ
Inception Date Jun 11, 2021
Provider Invesco
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 45.58% of assets
| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc... | GILD | 7.67% |
| Amgen Inc. | AMGN | 7.14% |
| Vertex Pharmaceutica... | VRTX | 6.25% |
| Regeneron Pharmaceut... | REGN | 6.10% |
| Alnylam Pharmaceutic... | ALNY | 5.15% |
| Astrazeneca PLC | AZN | 4.75% |
| Insmed Incorporated | INSM | 2.38% |
| Argenx Se | ARGX | 2.10% |
| Biogen Inc. | BIIB | 2.02% |
| Summit Therapeutics ... | SMMT | 2.02% |
Dividends Dividend Yield 1.05%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 23, 2025 | $0.0287 | Jun 27, 2025 |
| Mar 24, 2025 | $0.0402 | Mar 28, 2025 |
| Dec 23, 2024 | $0.0619 | Dec 27, 2024 |
| Sep 23, 2024 | $0.0894 | Sep 27, 2024 |
| Jun 24, 2024 | $0.0506 | Jun 28, 2024 |
